Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102
Clinical trial NCT04600284 · COMPLETED
Trial details
- NCT number
- NCT04600284
- Sponsor
- Addpharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-16
- Primary completion
- 2021-01-20
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.